Ecolab reported an 11% increase in adjusted earnings per share for the second quarter of 2026, driven by a 5% rise in organic sales. Pricing strengthened to 4% in the quarter and is expected to reach 5% to 6% in the second half, while volume grew 1% despite a nearly 1% headwind from Middle East disruptions. Among its growth engines, Life Sciences accelerated to 15% growth with a mid-20% operating income margin, Global High-Tech surged 29% and is approaching $1.5 billion in annualized sales, and Ecolab Digital grew 27%. The company maintained its 2027 operating margin target of 20% and issued full-year 2026 EPS guidance of $8.05 to $8.25, representing 7% to 10% growth over the prior year.
Ecolab IncEcolab reported 11% adjusted EPS growth and raised full-year guidance, indicating strong financial performance.